Safety and efficacy of filgotinib in Japanese patients with rheumatoid arthritis: Week 156 interim results in FINCH 4

FIL200 and FIL100 were generally well tolerated by Japanese patients, without new, unexpected adverse events.

Authors

Tsukasa Matsubara (ORCID: https://orcid.org/0000-0002-3342-3419)
Bernard Combe (ORCID: https://orcid.org/0000-0003-4002-1861)
Peter Nash (ORCID: https://orcid.org/0000-0002-2571-788X)
Yoshiya Tanaka (ORCID: https://orcid.org/0000-0002-0807-7139)
Kunihiro Yamaoka (ORCID: https://orcid.org/0000-0001-8858-9435)
Tatsuya Atsumi (ORCID: https://orcid.org/0000-0001-5657-962X)
Tsutomu Takeuchi (ORCID: https://orcid.org/0000-0003-1111-8218)
Alena Pechonkina
Koichi Amano (ORCID: https://orcid.org/0000-0002-4228-2056)
Shintaro Hirata (ORCID: https://orcid.org/0000-0002-2474-9943)
Naoki Ishiguro (ORCID: https://orcid.org/0000-0003-2041-4035)
Mark C. Genovese (ORCID: https://orcid.org/0000-0001-5294-4503)
Francesco De Leonardis (ORCID: https://orcid.org/0009-0003-3247-4462)
Akira Kondo (ORCID: https://orcid.org/0000-0001-9808-6989)
Haruhiko Fukada
Jie Liu (ORCID: https://orcid.org/0009-0006-5054-4550)